Cargando…
ERK Inhibitor Enhances Everolimus Efficacy through the Attenuation of dNTP Pools in Renal Cell Carcinoma
The clinical efficiency of everolimus, an mammalian target of rapamycin (mTOR) inhibitor, is palliative as sequential or second-line therapy for renal cell carcinoma (RCC). However, the limited response of everolimus in RCC remains uncertain. In the present study, everolimus-resistant RCC models wer...
Autores principales: | Zou, Yun, Li, Wenzhi, Zhou, Juan, Zhang, Jin, Huang, Yiran, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374702/ https://www.ncbi.nlm.nih.gov/pubmed/30771617 http://dx.doi.org/10.1016/j.omtn.2019.01.001 |
Ejemplares similares
-
Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools
por: Kumar, Dinesh, et al.
Publicado: (2011) -
Reciprocal regulation of autophagy and dNTP pools in human cancer cells
por: Chen, Wei, et al.
Publicado: (2014) -
Suppression of the E. coli SOS response by dNTP pool changes
por: Maslowska, Katarzyna H., et al.
Publicado: (2015) -
dNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages
por: Hollenbaugh, Joseph A, et al.
Publicado: (2014) -
Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages
por: Shepard, Caitlin, et al.
Publicado: (2019)